Imagin Medical Reports Research Study Progress

VANCOUVER, British Columbia and BOSTON, July 17, 2018 (GLOBE NEWSWIRE) — Imagin Medical (CSE:IME) (OTCQB:IMEXF) (Frankfurt:DPD2) (Stuttgart:DPD2) (“Imagin” or the “Company”) announced today favorable results in the 10-subject investigator-sponsored research...